Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ElizSMcKenna
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ElizSMcKenna
-
Prikvačeni tweet
Just published in
@CD_AACR to coincide with the highly anticipated presentation at#Targets19: The#KRASG12C Inhibitor, MRTX849, Provides Insight Toward Therapeutic Susceptibility of#KRAS Mutant Cancers in Mouse Models and Patientshttps://cancerdiscovery.aacrjournals.org/content/early/2019/10/22/2159-8290.CD-19-1167 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
Our discussion of the very nice paper on the role of pyroptosis and the immune system in targeted therapy responses in melanoma by
@antiDanImmunity@AndrewEAplin in@CD_AACR is online now!https://cancerdiscovery.aacrjournals.org/content/10/2/176.abstract …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
In a study funded by
@theNCI, researchers@USC showed that circulating tumor cells (#CTCs) from patients with breast cancer recapitulate patterns of#metastasis in mice and reveal drivers of metastatic growth in the brain@CD_AACR http://bit.ly/3950wEY .pic.twitter.com/XHJ8ionbLf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction | Cancer Discoveryhttps://cancerdiscovery.aacrjournals.org/content/early/2020/01/24/2159-8290.CD-19-0813 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Elizabeth McKenna proslijedio/la je Tweet
Great review on the current therapeutic landscape in AML!https://twitter.com/LeukemiaMDA/status/1224777042434150400 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
Great review and looking forward to hosting
@MaraShermanLab on March 23rd@KimmelCancerCtr. A seminar not to be missed (Bluemle Life Sciences Building, noon)!!!https://twitter.com/MaraShermanLab/status/1224426326515281920 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
Great review on fibroblast heterogeneity in Pancreatic cancer by
@MaraShermanLab!!https://twitter.com/marashermanlab/status/1224426326515281920 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Had a fantastic time visiting
@UMRogelCancer - thank you all for your gracious hospitality, especially@LyssiotisLab for hosting and@jamesNbeaumont for making sure everything went smoothly. Hope to see you all again soon!pic.twitter.com/iIlRCXuPMX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
Advances in the Treatment of Acute Myeloid
#Leukemia: New Drugs and New Challenges | http://bit.ly/2Ot1BP0 via@CD_AACR |@NicholasShortMD, Konopleva,@TapKadia,@GBorthakur, Ravandi, DiNardo, and@Daver_Leukemia of@MDAndersonNews@LeukemiaMDA.#endcancer#leusm#AMLHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
Very proud of this review on novel AML therapeutics now published in
@CD_AACR !https://twitter.com/LeukemiaMDA/status/1224777042434150400 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
@ElizSMcKenna, executive editor, joins us@UMRogelCancer to talk to about@CD_AACR !pic.twitter.com/4CfVANUC0K
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you so much for hosting me!! I had a wonderful visit!!https://twitter.com/lyssiotislab/status/1224748682311950336 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
Congrats! FADD and death receptor signaling came up also in our screens: https://doi.org/10.1182/blood.2019002121 ….
@NathanSinghLab1 et al dig deeper into this to show how leukemia cells resistant to death receptor apoptosis induce dysfunction in CAR T cells, explaining primary resistance@CD_AACRhttps://twitter.com/NathanSinghLab1/status/1222881245660635138 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
Pediatric cancer survivorship portal released. “We want to make this data accessible to as many types of scientific researchers & clinicians as possible." -Dr. Alex Gout, lead scientist of the St. Jude Cloud project. http://ow.ly/1gNT50y8ttn
#bioinformatics@CD_AACR@haloupekpic.twitter.com/pnVMTrJnSo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
From the January issue: The
#KRASG12C inhibitor MRTX849 provides insight into therapeutic susceptibility of#KRAS-mutant cancers in mouse models and patients. http://bit.ly/2vNbMYb pic.twitter.com/MHdWeVi40r
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
From the January issue: The first-in-human
#ClinicalTrial of#adenosine-pathway blockade for cancer#immunotherapy@lawfong@UCSF#A2AR#KidneyCancer http://bit.ly/3b7YWnz pic.twitter.com/78vIfcdG8j
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Very excited to share this important review in
@CD_AACR by@MaraShermanLab synthesizing all the recent discoveries on CAF heterogeneity in#PancreaticCancer!https://twitter.com/marashermanlab/status/1224426326515281920 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
This is an important invited commentary from
@MaraShermanLab in@CD_AACR on a “grand unification” strategy for all of the recently reported CAF heterogeneity studies in#PancreaticCancerhttps://twitter.com/marashermanlab/status/1224426326515281920 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
State unlocked: Michigan - excited for my visit to
@UMRogelCancer!pic.twitter.com/4k80FftH9t
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Elizabeth McKenna proslijedio/la je Tweet
Associate Editor
@TaliLev123 is at#NGI2020- be sure to say hello! http://bit.ly/2GMz0Qx pic.twitter.com/VqleIVOMzo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.